(Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -311.96%-1.03M | -140.80%-2.56M | 92.75%-1.92M | 97.11%-157.2K | 95.92%-446.41K | 95.79%-249.49K | 74.20%-1.06M | -395.72%-26.46M | -217.27%-5.45M | -491.15%-10.95M |
Net income from continuing operations | -416.21%-2.3M | 0.80%-2.91M | 68.72%-9.46M | 63.54%-3.65M | 78.68%-2.43M | 91.70%-445.9K | 14.91%-2.93M | -342.18%-30.23M | -243.27%-10.01M | -534.72%-11.4M |
Operating gains losses | --0 | ---73.71K | --28.29K | --0 | ---- | ---- | ---- | ---- | ---- | ---157.83K |
Depreciation and amortization | -13.02%167.11K | -48.15%162.03K | -13.37%888.84K | -74.28%78.11K | 13.06%306.1K | -23.84%192.14K | 56.75%312.5K | 129.43%1.03M | 100.64%303.65K | 76.78%270.73K |
Asset impairment expenditure | ---- | ---- | -99.55%10.77K | --0 | --0 | ---- | ---- | --2.37M | --1.57M | --803.16K |
Remuneration paid in stock | ---- | ---- | -56.99%675.96K | ---- | ---- | ---- | ---- | --1.57M | ---- | ---- |
Remuneration paid in stock | -81.56%76.14K | 74.00%615.78K | -48.97%1.96M | -49.37%539.61K | -57.47%650.56K | -56.25%412.82K | 19.51%353.9K | 212.89%3.84M | 51.82%1.07M | 466.14%1.53M |
Deferred tax | 128.88%480.83K | ---20.03K | -15,260.34%-2.1M | 3.92%-530.24K | 53.88%99.81K | -604.25%-1.66M | --0 | --13.82K | ---551.88K | --64.86K |
Other non cashItems | 92.59%682.61K | 192.91%842.86K | -31.05%2.9M | -51.40%1.06M | -17.40%1.2M | 59.09%354.43K | -17.56%287.76K | --4.21M | --2.19M | 21,687.07%1.45M |
Change In working capital | -118.00%-160.4K | -229.64%-1.18M | 134.24%3.17M | 198.20%1.66M | 91.56%-296.32K | 135.68%891K | 158.51%912.46K | -5,220.44%-9.26M | -294.37%-1.69M | -621.38%-3.51M |
-Change in receivables | -228.39%-478.15K | -89.10%78.6K | 138.61%1.62M | 166.33%1.11M | 94.88%-61.56K | -138.77%-145.6K | 142.30%721.27K | -300.51%-4.2M | -1,200.34%-1.67M | -197.99%-1.2M |
-Change in inventory | -114.13%-99.77K | -227.17%-890.32K | 150.80%1.65M | 96.90%-49.86K | 245.00%290.27K | 210.51%706.33K | 188.23%700.11K | -905.55%-3.24M | -456.96%-1.61M | 24.37%-200.19K |
-Change in prepaid assets | -12.36%170.07K | -216.49%-413.47K | 147.98%922.73K | -71.50%275.88K | 103.54%97.83K | 133.91%194.07K | -19.96%354.95K | -211.52%-1.92M | 1,456.74%968K | -462.83%-2.76M |
-Change in payables and accrued expense | 81.67%247.44K | 104.89%42.24K | -1,046.25%-1.02M | -46.85%328.69K | -195.08%-622.87K | 108.20%136.2K | -274.32%-863.86K | -94.05%107.99K | -0.34%618.47K | -2.58%655.08K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -311.96%-1.03M | -140.80%-2.56M | 92.75%-1.92M | 97.11%-157.2K | 95.92%-446.41K | 95.79%-249.49K | 74.20%-1.06M | -395.72%-26.46M | -217.27%-5.45M | -491.15%-10.95M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -161.23%-124.86K | -115.31%-27.34K | 107.45%232.81K | 95.89%-26.67K | 123.00%128.67K | 94.41%-47.8K | 116.81%178.61K | -108.64%-3.13M | 27.24%-648.8K | -382.92%-559.49K |
Net PPE purchase and sale | -161.23%-124.86K | -115.31%-27.34K | 107.74%232.81K | 95.73%-26.67K | 127.55%128.67K | 94.41%-47.8K | 116.81%178.61K | -112.74%-3.01M | 22.68%-624.8K | -303.12%-467.04K |
Net intangibles purchas and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -39.31%-116.45K | 71.29%-24K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -161.23%-124.86K | -115.31%-27.34K | 107.45%232.81K | 95.89%-26.67K | 123.00%128.67K | 94.41%-47.8K | 116.81%178.61K | -108.64%-3.13M | 27.24%-648.8K | -382.92%-559.49K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -25.84%-1.05M | 26.56%-89.32K | -108.55%-1.91M | 13.93%-865.15K | 72.12%-88.41K | -115.76%-837.71K | -100.66%-121.62K | -23.12%22.36M | -107.25%-1.01M | -103.40%-317.15K |
Net issuance payments of debt | 16.97%-87.77K | 27.46%-87.29K | -102.26%-400.24K | 65.36%-87.11K | -185.44%-87.09K | -17.59%-105.71K | -100.67%-120.33K | 3,045.99%17.68M | -862.36%-251.48K | 116.10%101.93K |
Net common stock issuance | --0 | ---873 | --0 | --0 | ---- | ---- | --0 | -79.98%5.94M | --0 | -99.16%84.16K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | -32.02%-966.37K | 10.35%-1.16K | -20.34%-1.51M | -3.22%-778.05K | 99.74%-1.32K | ---732K | ---1.3K | ---1.26M | ---753.75K | ---503.25K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -25.84%-1.05M | 26.56%-89.32K | -108.55%-1.91M | 13.93%-865.15K | 72.12%-88.41K | -115.76%-837.71K | -100.66%-121.62K | -23.12%22.36M | -107.25%-1.01M | -103.40%-317.15K |
Net cash flow | ||||||||||
Beginning cash position | -37.20%8.9M | -23.71%11.58M | -32.24%15.18M | -43.32%12.63M | -61.79%13.03M | -60.17%14.17M | -32.24%15.18M | 14,820.26%22.4M | 99.94%22.28M | 804.21%34.11M |
Current changes in cash | -94.43%-2.21M | -165.99%-2.68M | 50.18%-3.6M | 85.23%-1.05M | 96.57%-406.15K | 22.71%-1.13M | -107.65%-1.01M | -132.46%-7.22M | -163.10%-7.1M | -260.49%-11.83M |
End cash Position | -48.66%6.69M | -37.20%8.9M | -23.71%11.58M | -23.71%11.58M | -43.32%12.63M | -61.79%13.03M | -60.17%14.17M | -32.24%15.18M | -32.24%15.18M | 99.94%22.28M |
Free cash from | -287.72%-1.15M | -143.05%-2.59M | 93.24%-2M | 96.98%-183.87K | 96.08%-451.38K | 95.62%-297.29K | 79.46%-1.07M | -332.79%-29.58M | -133.70%-6.1M | -484.78%-11.51M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.